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Abstract: The World Health Organization recently stated that new sources of antibiotics are urgently
required to stem the global spread of antibiotic resistance, especially in multiresistant Gram-negative
bacteria. Although it was thought that many of the original sources of antibiotics were exhausted, in-
novative research has revealed promising new sources of antibiotic discovery in traditional medicine
associated with Streptomyces. In this work we investigated the potential of a specific limestone
grassland soil, associated with Irish folk medicine, as a new source of antimicrobial discovery.
Using selective enrichment and isolation techniques on a limestone grassland soil sample obtained
from Boho, West Fermanagh, we isolated Streptomyces sp. CJ13. This bacterium inhibited the growth
of a broad range of pathogens in vitro including Gram positive Staphylococcus aureus (MRSA 43300)
and Gram negative multiresistant Pseudomonas aeruginosa (PA01), as well as the anaerobic bacteria
Propionibacterium acnes and the yeast Starmerella bombicola. Genome sequencing and phylogenetic
analysis revealed Streptomyces sp. CJ13 to be closely related to an unclassified Streptomyces sp.
MJM1172, Streptomyces sp. Mg1 and two species known as Streptomyces sp. ICC1 and ICC4 from a
karst region in British Columbia. The closest type species to Streptomyces sp. CJ13 was Streptomyces
lavendulae subspecies lavendulae. Analysis of Streptomyces sp. CJ13 whole genome sequence using
the secondary metabolite prediction tool antiSMASH revealed similarities to several antibiotic gene
synthesis clusters including salinichelin, mediomycin A, weishanmycin, combamide, heat stable
antifungal factor and SAL-2242. These results demonstrate the potential of this alkaline grassland
soil as a new resource for the discovery of a broad range of antimicrobial compounds including those
effective against multiresistant Gram negative bacteria.
Keywords: soil; antibiotics; Streptomyces; traditional medicine; MRSA
1. Introduction
It is almost taken for granted that the days of incurable diseases and the uncontrol-
lable spread of infections are a thing of the past. However, the rising tide of multiresistant
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pathogens serves as a wake-up call to researchers that new sources of antimicrobial com-
pounds are an urgent priority [1,2]. The world health organisation (WHO) has described
the current shortage of new antibiotics as a threat to the containment of drug resistant
infections, stating that it is insufficient to tackle the challenge of antimicrobial resistance.
There have been several attempts to revive the antibiotic discovery pipeline after
the lull of the past few decades by using automated processes. This mainly took the
form of combinatorial chemistry which synthesized large repositories of small compounds
derived from antibiotic core structures and screened these against an array of pathogenic
bacterial antigens [3,4]. The investment in this technology did not produce as many lead
compounds as expected, perhaps due to the limited number of core structures. Although
chemical modification of existing antibiotic core units is the current failsafe of antimicrobial
chemotherapy [5], major investment in antibiotic discoveries was abandoned by major drug
companies mainly due to high cost and limited returns scenarios [4]. As a consequence,
most of the new antibiotic discoveries are now in the hands of small to medium enterprises
(SMEs) that have fewer resources [2].
The discovery of new antibiotics is now heavily reliant on innovative solutions.
Some researchers have returned to isolation of antimicrobial-producing organisms from
the natural environment as it offers the prospect of increased chemical diversity of core
antibiotic structures [6]. This has included an examination of traditional medicine as
a new source of lead compounds [7,8]. One of the inspirations for research into tradi-
tional medicine may have come from Geoffrey Cordell, who devised a series of systematic
searches of plant metabolites for anticancer medicines. This included an ethnomedical
approach, which evaluated and highlighted the importance of written or historical evi-
dence from traditional medicinal practice [9]. Additionally, there have been a number of
reports of epiphytic and endophytic species of Streptomyces associated with traditional
medicine plants from many continents [10,11]. Even more interesting is the discovery of
traditional medicine soils [11]. Unlike the antimicrobial discoveries during the peak of post
war antibiotic discovery, traditional medical soils are quite specific in their character and
location. These have been reported for the Red Soil of Jordan, [12] and glacial clay from
British Columbia, Canada [13,14].
Although traditional medicines are quite well known for Chinese and African tra-
ditions, many European traditions have almost disappeared or are the preserve of rural
backwaters. Some of the last vestiges of these traditions can be found on the furthest fringes
of Western Europe on the island of Ireland [15]. Although some of this traditional medicine
has been partially documented [16,17], many of the traditional cures were closely guarded
secrets passed down through generations that have now almost faded from memory. How-
ever, these cures are still associated with specific habitats which enables us to unravel some
of their common characteristics. The area of the West Fermanagh Scarplands is one such
area. It constitutes the majority of limestone grassland in Northern Ireland, a consequence
of the weathering of the underlying limestone bedrock which forms a thin layer of slightly
alkaline soil. The area is well known for its caves, limestone pavement and upland bog,
which provide unique habitats for a large diversity of flora. The area is also known for
traditional medicines or “cures”, some of which are publicly known and others are secrets
passed down through generations. According to anecdotal evidence, this soil has been
used for millennia for treatment of various ailments including skin infections, ring worm
and digestive problems. In previous research we isolated Streptomyces sp. myrophorea
from this very specific area of upland grassland that had inhibitory activity against several
of the most common hospital multiresistant (ESKAPE) pathogens [18].
However, respecting the strong sensitivities around this specific soil, which remains
within consecrated ground, we feel this cannot be considered as an exploitable resource
for scientists in any normal sense. Instead, we returned to an adjacent upland alkaline
grassland region which is still associated with traditional medicine approximately a kilo-
meter from our original discovery to examine whether the same type of soil could be a new
resource for antimicrobial discovery.
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2. Materials and Methods
2.1. Soil Samples
Soil sampling permissions were granted by a local landowner in Boho, County Fer-
managh, Northern Ireland, at a distance of a few kilometers from a previous examina-
tion [18].
2.2. Soil pH Measurement
Triplicate samples were used to measure the soil pH using a Jenway standard digital
3510 pH meter. Approximately 10 g of field soil was dissolved with 20 mL of water, shaken
gently to form a slurry, incubated for 30 min and measured [19].
2.3. Microorganisms
S. aureus MRSA (ATCC 43300), S. aureus (MSSA), Pseudomonas aeruginosa PA01, Starmerella
bombicola, Bacillus subtilis (ATCC 6633), Escherichia coli (ATCC 25922) and Propionibacterium
acne (DSM 1897) were kind gifts from Prof. Ibrahim Banat (Ulster University).
2.4. Soil Sample Pretreatment
Soil samples were air dried in sterile laminar flow cabinet. Soil samples were then
incubated for one hour at 60 ◦C, dry heat. A small fraction of this soil was removed and
dissolved in 1 mL of sterile water. This was mixed on a rotary shaker for 30 min before
removing 10 µL aliquots and inoculating onto one-fifth nutrient strength ISP2 containing
0.03% chlorhexidine gluconate (to discourage fungi) and original mineral extract from soil.
These Petri dishes were then incubated for 2 h at room temperature followed by 2 weeks at
8 ◦C.
2.5. Media
The core media used in these experiments were plain “base” agar, ISP-2 agar, TSA,
Muller Hinton and Sabouraud dextrose agar (Oxoid, Thermo Fisher Scientific Inc, Bas-
ingstoke, Hampshire, UK). Sterilized washes of original soil were also used in some media
as a mineral supplement. These were prepared by taking a small portion of the original
soil from the isolation area, mixing with sterile water (5 g per 20 mL w/v) and vortexed
for several minutes (to supplement with essential minerals that might not be found in
laboratory media). This was centrifuged in small aliquots at 14,000× g. It was then passed
through a 0.2 µm filter. Five mL of this wash may be added to 200 mL of agar.
2.6. Antibiotic Tests
Antimicrobial tests were based on a modification of an ultrasensitive assay developed
by Lehrer [20] and a Streptomyces overlay method [21]. Briefly, several wells were cored
from sterilized base agar without nutrients once it had cooled. These were filled with
either antibiotic solutions or agar cores from Streptomyces cultivation (killed by inverting
Streptomyces agar plate over 4 mL chloroform in a watch glass for 1 h). Once the antibiotics
had absorbed into the test wells and surrounding agar, several drops of cooled base agar
were added to seal the wells that contained liquid (lest there was any spillover once the top
layer of agar was added) and to hold the Streptomyces agar plugs in position. Test bacteria
were added to 15 mL of hand warm (no more than 42 ◦C) Muller Hinton agar. This vessel
was rotated to mix the organisms evenly and poured over the base agar. In cases where
the organisms were not amenable to this method, such as S. bombicola, the organisms were
streaked over the surface of the agar using a sterile swab. In cases where test pathogen
growth was weak on Muller Hinton agar, this was substituted by TSA in the case of
S. aureus or Sabouraud agar in the case of S. bombicola. Plates were incubated overnight
at 28 ◦C. The presence of a clear zone in the test pathogen indicated inhibitory activity.
The procedure was similar for anaerobic organisms such as Propionibacterium acnes except
that the final incubation conditions were 24 h in an anaerobic cabinet.
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2.7. DNA Extraction
A single colony of Streptomyces was mixed in 200 µL sterile PBS and inoculated into
25 mL of sterile ISP2 media. The broth was shaken at 28 ◦C for two days. A subsample was
taken to determine the purity of the bacteria. The rest of the sample was pelleted for 10 min
at 4000× g. The pellet was suspended in 500 µL of the cryopreservant from a barcoded
bead tube supplied by MicrobesNG. The whole genome sequencing was performed by
Microbes NG (Units 1–2 First Floor, The BioHub, Birmingham Research Park, UK).
2.8. Sequencing Protocol
Three beads from the cryopreservant tube were washed with extraction buffer con-
taining lysozyme (or lysostaphin for Staphylococcus sp.) and RNase A, incubated for 25 min
at 37 ◦C. Proteinase K and RNaseA were added and incubated for 5 min at 65 ◦C. Genomic
DNA was purified using an equal volume of SPRI beads and resuspended in EB buffer.
DNA was quantified in triplicate using the Quantit dsDNA HS assay in an Eppendorf
AF2200 plate reader. Genomic DNA libraries were prepared using Nextera XT Library
Prep Kit (Illumina, San Diego, CA, USA) following the manufacturer’s protocol with the
following modifications: two nanograms of DNA instead of one were used as input, and
PCR elongation time was increased to 1 min from 30 s. DNA quantification and library
preparation were carried out on a Hamilton Microlab STAR automated liquid handling
system. Pooled libraries were quantified using the Kapa Biosystems Library Quantification
Kit for Illumina on a Roche light cycler 96 qPCR machine. Libraries were sequenced on the
Illumina HiSeq using a 250 bp paired end protocol. Reads were adapter-trimmed using
Trimmomatic 0.30 with a sliding window quality cut off of Q15 [22]. De novo assembly
was performed on samples using SPAdes version 3.7 [23] and contigs were annotated using
Prokka 1.11 [24].
2.9. Phylogenetic Tree
Whole genome sequences (WGS) for all Streptomycetes were retrieved autonomously
from GenBank using a WGET script. Genomes were annotated in Prokka [24] and the result-
ing translated CoDing Sequence (CDS) files (.faa files) were used to generate a multilocus,
concatenated alignment of 400 proteins in PhyloPhlan [25]. Proteins used for the align-
ment were shown to be conserved among bacterial genera [25]. A maximum-likelihood
phylogeny was reconstructed in FastTree [26] and rendered in iTOL [27]. The robustness of
the phylogeny was assessed using 1000 bootstrap replications. Tree was outgroup-rooted
along the lineage leading to Frankia.
2.10. In Silico Secondary Metabolite Analysis
Genome sequences were analysed using subsystem technology (RAST) version 4.0
(http://rast.nmpdr.org) and SEED [28]. Similarities to known antibiotic gene clusters and
other secondary metabolites were predicted by antiSMASH [29,30].
2.11. Accession Numbers
The whole genome of Streptomyces sp. CJ13 was deposited at DDBJ/ENA/GenBank
under the accession JAAZTW000000000. The version described in this paper is version
JAAZTW010000000, BioProject PRJNA433829 BioSample SAMN14520815.
3. Results
3.1. Characterisation of Streptomyces sp. Isolate CJ13
A limestone grassland soil sample was examined from an area classified as calcareous
grassland/acid flush mosaic. Soil pH was measured at an average of pH 7.3 (over four
samples), which is a neutral to slightly alkaline soil. The Streptomyces sp. isolate CJ13
was selectively cultivated from the soil sample using base agar with a mineral rinse of the
original soil sample. Although other Streptomyces were cultivated, colonies of Streptomyces
sp. CJ13 had the greatest inhibitory activity in provisional tests. The sporing colonies of
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this Streptomyces were subcultured onto ISP-2 media (also with soil mineral rinse) and
labelled as Streptomyces sp. isolate CJ13.
Morphologically, Streptomyces sp. CJ13 appeared as hard raised dark colonies with
light purple or white spores on ISP-2 agar (Figure 1). In most cases, the colonies produced
a diffusible brown pigment but in other variants this colour was weak or even absent.
The original isolate produced two varieties of colonies depending on age and cultivation
conditions characterised by either white or purple spores (Figure 1). Later whole genome
sequencing confirmed the species belonged to the Streptomyces genus through a comparison
with 930 other species of Streptomyces.
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Microscopically, hyphae of Streptomyces sp. CJ13 appeared as thin strands with short
branches occasionally bunched together into thicker fibers (Figure 2).
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Table 1. Cont.
Classification




Cell shape: Branched hyphae
Oxygen: Aerobic, anaerobic tolerant
Spores: Purple/white
pH in ISP2 broth 6.85 to 7.85
3.2. Antibiotic Tests
3.2.1. Growth Inhibition by Streptomyces sp. CJ13
Streptomyces sp. CJ13 was cultivated on ISP2-agar. Agar cores were removed from
these plates and tested against bacteria and fungi. Tests were performed a minimum of
three times. In vitro tests show that Streptomyces sp. CJ13 inhibited the growth of S. aureus
(MRSA), P. aeruginosa, B. subtilis, P. acnes and S. bombicola, but had no effect on the growth
of E. coli (Figure 3). This antibiotic activity varied depending on the pigmentation of
the Streptomyces. Highly pigmented variants of Streptomyces sp. CJ13 (d) showed more
inhibitory activity against Gram negative bacteria such as Pseudomonas, as well as the yeast
S. bombicola. Lighter coloured Streptomyces (l) had more effect on Gram positive organisms
(Figure 3 and Table 2).
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Figure 3. I i itory effects of Streptomyces sp. isolate CJ13 dark (d) and light (l) variants on S. aureus
(MRSA 43300), P. aeruginosa, B. subtilis, S. aureus (MSSA), E. coli, P. acne and S. bombicola. Control antibi-
otics (µg): cephalothin (CEP), teichoplanin (TE), gentimicin (CN), erythromycin (E), chlorhexidine (CHL
50 µg), vancomycin (VAN) and blank (B). Tests performed a minimum of three times.
Table 2. Zone of inhibition (ZOI) in mm produced by agar cores from Streptomyces sp. isolate CJ13
dark and light variants on S. aureus (MRSA 43300), P. aeruginosa, B. subtilis, S. aureus (MSSA), E. coli,
P. acne and S. bombicola. Concentration of antibiotics in µg: cephalothin (CEP), teichoplanin (TE),
gentimicin (CN), erythromycin (E), chlorhexidine (CHL 50 µg), vancomycin (VAN) and blank (B).
Tests performed a mini um of three times.
ti icrobial Micro rg i
MSSA S. bombicola B. subtilis E. coli P. aeruginosa MRSA
CJ13 Dark 13 18 11 0 13 14
CJ13 Light 12 6 0 0 10 13
CEF 20 33 - 0 - 0 18
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Table 2. Cont.
Antimicrobial Microorganisms
MSSA S. bombicola B. subtilis E. coli P. aeruginosa MRSA
TE 20 18 - - - - 15
TE 10 - - - - 18 -
TE 1 - - 24 - - -
CN 10 na - - 17 - -
E 10 na - - 0 - -
CHL 50 na - - - - -
3.2.2. Stability of Inhibitory Factor from Streptomyces sp. CJ13
We also examined the effects of heat and storage on the stability of the inhibitory
substances present in the growth media of Streptomyces sp. CJ13. Antimicrobial tests
showed that the agar on which strains of Streptomyces sp. CJ13 were grown was still
inhibitory even after 11 months of storage at 4–10 ◦C. However, this activity could be
reduced by as much as 40% after 11 months storage. We were unable to measure any
inhibitory activity in liquid cultures. The heat stability of the inhibitory component of
Streptomyces sp. CJ13 present in agar that had been stored for 2 months between 4 and
10 ◦C was tested by heating agar cores to 100 ◦C in a heat block for five minutes with 300 µL
sterile water (to improve heat transfer) in an Eppendorph tube, rapidly cooling on ice and
transferring into a standard inhibition test. These results showed that inhibitory activity
was still detectable even after exposure to these high temperatures (Table 3).
Table 3. Effect of temperature on antimicrobial activity of agar cores from Streptomyces sp. isolate
CJ13. Agar from Streptomyces sp. CJ13 were incubated against cultures of S. aureus (MRSA 43300),
P. aeruginosa (PA01) and S. bombicola. Zone of inhibition (ZOI) measured in mm. Antibiotic controls:
cephalothin (CEP) 20 µg, teichoplanin (TE) 20 µg and chlorhexadine (CHL 50 µg). Tests performed a
minimum of three times.
Scheme 20. ZOI at 20 ◦C ZOI at 100 ◦C CEP CHL TE
MRSA 16 9 18 - 17
P. aeruginosa 12 9 - - 16
S. bombicola 22 16 - 18 -
3.3. Whole Genome Sequencing of Streptomyces CJ13
The whole genome sequence of Streptomyces sp. CJ13 was characterised using rapid
annotation subsystem technology (RAST), [28] (Figure 4, Table 4).
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Table 4. Features of Streptomyces sp. CJ13 genome.
Attribute. Streptomyces sp. CJ13




Number of Contigs 901
Number of Subsystems 314
Total genes 9260
Number of RNAs 86
3.4. Phylogeny of Streptomyces sp. CJ13
Streptomyces sp. CJ13 sits within a well-supported clade closely related to Strepto-
myces sp. MJM1172 (Figure 5). The sister clade below Streptomyces sp. CJ13 is composed
of Streptomyces sp. ICC1 and ICC4, isolated from a cave in British Columbia, Canada,
a similar karst environment to Boho, West Fermanagh, where Streptomyces sp. CJ13 was
isolated [31,32]. These isolates are related to the clade containing S. lavendulae subspecies
lavendulae (Waksman et Curtis, 1916) [33], which match several phenotypic characteristics
of our isolate.
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3.5. Streptomyces sp. CJ13 Secondary Metabolite Prediction
In order to predict the potential synthesis of antibiotics by Streptomyces sp., CJ13,
we analysed its whole genome sequence using antiSMASH (antibiotics and secondary
metabolite analysis shell), which predicts the potential for synthesis of secondary metabolite
clusters [29]. Some of the secondary metabolites that we identified are common to many
species of Streptomyces, including: spore pigment, melanin, siderophores, alkylresorcinol
(phenolic lipid, also contact allergen) and hopene (condenses membranes and decreases
permeability) [34–36].
Most importantly antiSMASH predicted similarities from the whole genome sequence
of Streptomyces sp. CJ13 to known antibiotic gene clusters, including salinichelins [37],
antifungal factor [38], mediomycin A [39], weishanmycin [40], combamide (macrolac-
tam) [41] and SAL-2242 [42] (Table 5).
Table 5. Summary of antiSMASH (antibiotics and secondary metabolite analysis shell) 4.1.0 secondary
metabolite prediction of Streptomyces sp. strain CJ13 (values above 40% gene similarity).
Type Antibiotic Gene Cluster Similarity
NRPS Salinichelins 53%
NRPS Antifungal factor 50%
T1PKS Mediomycin A 46%
NRPS Weishanmycin 45%
T1PKS, NRPS Combamide (macrolactam) 44%
Lanthipeptide SAL-2242 44%
3.6. In Silico Prediction of Streptomyces sp. CJ13 Resistance Genes
It is thought that antibiotic resistance (AMR) coevolved with antibiotic production
in Streptomyces [43]. We therefore listed resistance clusters from Streptomyces sp. CJ13
(Table 6). We also noted similarities to metal resistance genes since these are also linked to
antimicrobial resistance [44] (Table 6).
Table 6. Antibiotic and metal resistance genes identified from WGS (whole genome sequences) of
Streptomyces sp. CJ13 (predicted by Rapid Annotation using Subsystem Technology (RAST)).
Biological Role. Protein Name
Aminoglycoside adenylyltransferases Aminoglycoside N6’-acetyltransferase (EC 2.3.1.82)
Resistance to fluoroquinolones DNA gyrase subunit B (EC 5.99.1.3)
Resistance to fluoroquinolones DNA gyrase subunit A (EC 5.99.1.3)
Beta-lactamase Beta-lactamase
Copper homeostasis Multicopper oxidase
Copper homeostasis Copper resistance protein
Copper homeostasis Copper-translocating P-type ATPase (EC 3.6.3.4)
Copper homeostasis Copper resistance protein
Copper homeostasis Multidrug resistance transporter,
Copper homeostasis: copper tolerance Cytoplasmic copper homeostasis protein
Magnesium and cobalt tolerance Magnesium and cobalt efflux protein
Cobalt–zinc–cadmium resistance Cobalt–zinc–cadmium resistance protein
Cobalt–zinc–cadmium resistance Transcriptional regulator
Mercuric reductase FAD-dependent NAD(P)-disulphide oxidoreductase
4. Discussion
There have been several attempts over the last few decades to replenish the antibiotic
discovery pipeline. This has become more urgent given the rise in reports of antimicrobial
resistance [45]. Rather than repeat older methods of antibiotic discovery, researchers have
tried new innovations. One such strand is the examination of traditional medicines for
antimicrobial producing bacteria or antimicrobials themselves. This follows from successful
generation of lead compounds in the field of cancer [9].
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In this manuscript, we isolated a species of Streptomyces (Streptomyces sp. CJ13) from
an alkaline grassland soil traditionally known for its healing properties. This had a broad
range of inhibitory activity against multiresistant bacteria, anaerobes and fungi. There are
many antibiotic producing species of Streptomyces associated with traditional medicines,
both as endophytes and epiphytes [10,11]. Many of the discoveries during the golden age
of antibiotics also came from soils. The difference between the older types of antimicrobial
surveys in soils and those that have been recently isolated from traditional medicine is
their specific soil character and location. For instance, Kisameet clay is based on a glacial
clay deposit found in British Columbia that inhibits ESKAPE pathogens [13,14]. Similarly,
traditional soil discoveries in Jordan focus on red soil that inhibits various pathogens [12].
Whilst our experiments were based on alkaline grassland soil, we did not test the whole
soil for antimicrobial activity but rather tried to selectively isolate Streptomyces from the
soil. Other studies have shown that karst regions, i.e. regions where there is dissolution of
the rocks, especially limestone, support the growth of many Streptomyces [46–48].
By coincidence, some of the closest phylogenetic matches to Streptomyces sp. CJ13
were Streptomyces sp. ICC 1 and ICC4 originating from the Iron Curtain Cave in Chilliwack,
British Columbia [32]. Both the West Fermanagh Scarplands and Iron Curtain Cave are
regions of karst and share other botanical species including Spiranthes romanzoffiana (Irish
lady’s-tresses) and Sisyrinchium bermudiana (blue-eyed grass). Additionally, both areas
also have indigenous soil-based traditional medicines: in British Columbia from Kisameet
Bay and in Fermanagh from the Boho area [13,18]. Streptomyces sp. CJ13 also shares
phylogenetic similarities with the larger group of S. lavendulae. This group was originally
described as Actinomyces lavendulae by Waksman and Henrici (1916), although relative
distinctions between Actinomycetes had not been formalised at that time [33].
One of the world’s most pressing health issues is treating multidrug resistant Gram-
negative bacteria. These can cause serious infections such as pneumoniae and urinary
tract infections, which are often difficult to treat [49]. Fortunately, there are many more
antibiotic discoveries for regulatory approval than in the previous decades, but still not
enough to meet projected patient needs [2]. The inhibitory activity of Streptomyces sp. CJ13
covered a surprisingly broad array of organisms, including Gram-negative, multiresistant
P. aeruginosa PA01.
The expression of antimicrobial activity varied between pigmentation types in our
experiments. This phenomenon was also noted in the Iron Curtain Cave (ICC) strains from
British Columbia [32]. To maintain a consistently high level of antibiotic activity, the ICC
group grew their isolates on minimal media at low temperatures over an extended period of
time [32]. This suggests that more antibiotics were induced by stressful growth conditions.
Streptomyces are known to have silent antibiotic gene synthesis clusters stimulated during
stress, microbial competition or interspecies communication [50–53]. In contrast to the
ICC strains of British Columbia, Streptomyces sp. CJ13 grew quite rapidly (in a number
of days) and also expressed antibiotic activity over that same time period. To maintain
optimal antibiotic production, we followed a regime similar to the ICC group using very
Spartan media. However, most of our antimicrobial experiments were derived from stocks
of Streptomyces sp. CJ13, which had been frozen at −80 ◦C in glycerol.
The phylogenetically related group S. lavendulae produce many antimicrobial sub-
stances, including ileumycin, mitomycin C, eurymycin, glomecidin, saframycin, laven-
damycin, angucycline, chlorocarcin, mimosamycin, streptothricin and
streptomycin [33,54–57]. Additionally, secondary metabolite prediction software showed
similarities to the antibiotic gene synthesis clusters for salinichelins, mediomycin A, weis-
hanmycin, combamide (macrolactam), heat stable antifungal factor and SAL-2242. How-
ever, preliminary studies of antimicrobial Streptomyces sp. CJ13 extracts by mass spectrom-
etry failed to find any identities with compounds in the Streptomyces or small molecule
databases (results not shown). This raises the possibility that the inhibitory activity detected
in Streptomyces sp. CJ13 could be from new antimicrobials. Further rounds of purification
and analysis by mass spectrometry and NMR might reveal the identity of these compounds.
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5. Conclusions
The discovery of new sources of antimicrobial compounds is still seen as a critical
priority to contain the global spread of multidrug resistant diseases. We have isolated
Streptomyces CJ13 from a soil associated with traditional Irish medicine that inhibits the
growth of a broad range of organisms, including multiresistant Gram-negative bacteria.
We are certain that this isolate represents a small fraction of the potential discoveries from
this soil, which could serve as a new resource for future antibiotic discovery.
Supplementary Materials: The following are available online at https://www.mdpi.com/2076-3
417/11/1/173/s1, Figure S1. Phylogenic comparison of Streptomyces sp. isolate CJ13 with 930
other Streptomycetes. Numbers at nodes are bootstrap values of 1000 pseudoreplicates—these are
percentages.
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